Madrigal Pharmaceuticals
MDGL
MDGL
91 hedge funds and large institutions have $143M invested in Madrigal Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 22 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
2% less capital invested
Capital invested by funds: $146M → $143M (-$3.51M)
47% less call options, than puts
Call options by funds: $373K | Put options by funds: $698K
Holders
91
Holding in Top 10
1
Calls
$373K
Puts
$698K
Top Buyers
| 1 | +$13.3M | |
| 2 | +$6.29M | |
| 3 | +$6.29M | |
| 4 |
Jennison Associates
New York
|
+$5.83M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.38M |
Top Sellers
| 1 | -$848K | |
| 2 | -$844K | |
| 3 | -$738K | |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$485K |
| 5 |
D.E. Shaw & Co
New York
|
-$325K |